Atlas Venture Fund X, L.P. 13D and 13G filings for Gemini Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-02-16 5:25 pm Purchase | 2021-02-05 | 13D | Gemini Therapeutics, Inc. GMTX | Atlas Venture Fund X, L.P. | 401,505 8.900% | 401,505 (New Position) | Filing |